As the vagally driven CAP can stop the action of NF-κB, adequate vagal signaling might modulate the severity of several viral infections, thus supporting complementary non-invasive vagal neuromodulation use in one-size-fits-all antiviral strategy, now in case of vaccine shortage or poor efficiency or after, for the upcoming pandemics. Here, NFKB1 is linked to viral infectious disease.